Merck eyes best day since 2016, gains help fuel pharma rally via @FT https://t.co/O6rJ0JZFNg — The Propell Group (@ThePropellGroup) April 9, 2018
Novartis buys US gene therapy group AveXis for $8.7bn via @FT https://t.co/C7l5AeqVoI — The Propell Group (@ThePropellGroup) April 9, 2018
1mg is raising fresh capital of ₹65 Cr from Sequoia and others https://t.co/C8JrDuP9mU @term_sheet
0 0
1mg is raising fresh capital of ₹65 Cr from Sequoia and others https://t.co/C8JrDuP9mU @term_sheet — The Propell Group (@ThePropellGroup) April 9, 2018
Celgene hunts deals to offset loss of Revlimid patent protection via @FT https://t.co/SNcvLynpAN — The Propell Group (@ThePropellGroup) April 9, 2018
What Walmart’s Earnings Transcripts Reveal (Or Don’t) About Its Healthcare Ambitions And Wall Street https://t.co/LzraYlabf6 via @cbinsights
0 0
What Walmart’s Earnings Transcripts Reveal (Or Don’t) About Its Healthcare Ambitions And Wall Street https://t.co/LzraYlabf6 via @cbinsights — The Propell Group (@ThePropellGroup) April [...]
Lawsuit claims Apple cribbed Apple Watch heart rate sensor tech, hints at work on glucose monitoring… https://t.co/RxpBNJnckr
0 0
Lawsuit claims Apple cribbed Apple Watch heart rate sensor tech, hints at work on glucose monitoring… https://t.co/RxpBNJnckr — The Propell Group (@ThePropellGroup) April 7, 2018
Melanoma trial failure deals heavy blow to immunotherapy hopes via @FT https://t.co/zi4tXV7Ao0 — The Propell Group (@ThePropellGroup) April 6, 2018
Digital health investors don’t want your buzzwords https://t.co/Qx3DIXKMtS — The Propell Group (@ThePropellGroup) April 5, 2018
Population measurement for health systems https://t.co/ce5KytGt6X — The Propell Group (@ThePropellGroup) April 4, 2018
Reinventing Health, Disease Diagnosis & Management, Drug Discovery https://t.co/TSSm2eErT6 — The Propell Group (@ThePropellGroup) April 3, 2018